One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

G-protein coupled receptors as drug targets: Heptares Therapeutics celebrates its tenth anniversary

Published on 6 July, 2017

Chris Tate – co-founder of Heptares Therapeutics, a company established to commercialise research from the LMB – discusses his work on G-protein coupled receptors. More…